A Study of 5-FUci Versus CPT-11 Plus CDDP Versus S-1 Alone in Advanced Gastric Cancer
Status:
Completed
Trial end date:
2007-01-01
Target enrollment:
Participant gender:
Summary
To investigate the superiority of a combination of irinotecan and cisplatin and the
non-inferiority of S-1 compared to continuous infusion of 5-FU in advanced gastric cancer
Phase:
Phase 3
Details
Lead Sponsor:
Japan Clinical Oncology Group
Collaborators:
Ministry of Health, Labour and Welfare, Japan Taiho Pharmaceutical Co., Ltd. Yakult Honsha Co., LTD